Eric Siemers - Net Worth and Insider Trading

Eric Siemers Net Worth

The estimated net worth of Eric Siemers is at least $352,728 dollars as of 2024-11-05. Eric Siemers is the Chief Medical Officer of Acumen Pharmaceuticals Inc and owns about 117,576 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $352,728. Details can be seen in Eric Siemers's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Siemers has not made any transactions after 2024-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Eric Siemers

To

Eric Siemers Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Siemers owns 1 companies in total, including Acumen Pharmaceuticals Inc (ABOS) .

Click here to see the complete history of Eric Siemers’s form 4 insider trades.

Insider Ownership Summary of Eric Siemers

Ticker Comapny Transaction Date Type of Owner
ABOS Acumen Pharmaceuticals Inc 2024-01-18 Chief Medical Officer

Eric Siemers Latest Holdings Summary

Eric Siemers currently owns a total of 1 stock. Eric Siemers owns 117,576 shares of Acumen Pharmaceuticals Inc (ABOS) as of January 18, 2024, with a value of $352,728.

Latest Holdings of Eric Siemers

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABOS Acumen Pharmaceuticals Inc 2024-01-18 117,576 3.00 352,728

Holding Weightings of Eric Siemers


Eric Siemers Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Siemers has made a total of 1 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the sale of 3,124 shares on January 18, 2024, which brought Eric Siemers around $11,590.

Insider Trading History of Eric Siemers

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Siemers Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eric Siemers Ownership Network

Ownership Network List of Eric Siemers

No Data

Ownership Network Relation of Eric Siemers

Insider Network Chart

Eric Siemers Owned Company Details

What does Acumen Pharmaceuticals Inc do?

Who are the key executives at Acumen Pharmaceuticals Inc?

Eric Siemers is the Chief Medical Officer of Acumen Pharmaceuticals Inc. Other key executives at Acumen Pharmaceuticals Inc include Chief Legal Office & Corp Sec Derek M Meisner , director & President and CEO Daniel Joseph Oconnell , and Chief Financial Officer Matt Zuga .

Acumen Pharmaceuticals Inc (ABOS) Insider Trades Summary

Over the past 18 months, Eric Siemers made 1 insider transaction in Acumen Pharmaceuticals Inc (ABOS) with a net sale of 3,124. Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net purchase of 5,161,290 shares made by Ra Capital Healthcare Fund Lp , a net sale of 41,949 shares made by Jeffrey L. Ives , and a net sale of 15,200 shares made by Daniel Joseph Oconnell .

In summary, during the past 3 months, insiders sold 0 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,281 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 5,161,290 shares were bought by its insiders, resulting in a net purchase of 5,085,009 shares.

Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acumen Pharmaceuticals Inc Insider Transactions

No Available Data

Eric Siemers Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Siemers. You might contact Eric Siemers via mailing address: C/o Acumen Pharmaceuticals, Inc., 427 Park Street, Charlottesville Va 22902.